Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

BrainStorm Receives $800, 000 Non-Dilutive Grant from Israel’s Office of the Chief Scientist

BrainStorm logo


BrainStorm Cell Therapeutics Inc. (OTC.QB: BCLI), announced today that Brainstorm Cell Therapeutics Ltd. was awarded a $800, 000 non-dilutive grant from Israel’s Office of the Chief Scientist (OCS) for the year 2014. The grant is intended to support BrainStorm’s clinical and product development for its innovative stem cell therapy candidate NurOwn.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

The OCS has supported BrainStorm Cell Therapeutics Ltd. since 2007, providing grants of a total of approximately $3 million until today. The Company is required to pay royalties to the OCS, amounting to 3% – 3.5% of revenues derived from sales of the products funded with these grants, but only up to the amount equal to 100% of the grants received plus LIBOR interest.

“We are thankful to the OCS for its continued support. The non-dilutive capital funding from the OCS will help facilitate our clinical trials in Israel and the USA as well as our continued product development, ” said Mr. Chaim Lebovits, BrainStorm’s President and Principal Executive Officer.

BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.